Novo Nordisk to restart liraglutide obesity studies (Reuters, 22 June 2010)

Lilly, Walmart to sell co-branded insulin (Reuters, 22 June 2010)

J&J cuts 2 deals for diabetes treatment (Associated Press, 23 June 2010)

23 Jun 2010

Johnson & Johnson will soon add to its portfolio of diabetes therapy by partnering up with two companies, one Swedish one Californian, in two separate deals to develop new medicines for type-1 and type-2 diabetes.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read